CAS 339086-80-5

Tadocizumab

CAS: 339086-80-5

Tadocizumab (C4G1) is a humanized monoclonal antibody targeting integrin αIIbβ3 with antiplatelet and antithrombotic effects.

Reinheit: 97.1% (SDS-PAGE); 97.2% (SEC-HPLC) - 97.1% (SDS-PAGE); 97.2% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 47.59 kDa

Ref: TM-T76979

Tadocizumab

CAS: 339086-80-5

Anti-IL-6 receptor humanized whole antibody, immunosuppressive drug, treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis and COVID-19

Ref: 3D-CLA1084